ADHD in the News 2025-11-06
FDA Announces Nationwide Recall of ADHD Medication—Check Your Cabinets Now
Fast Facts: Sun Pharmaceutical Industries has recalled several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse. The FDA classified the recall as Class II, indicating a low risk of serious health consequences but potential temporary or reversible effects. Patients are advised to check their prescription bottles and contact their healthcare provider or pharmacy for replacements or refunds.
Review finds no link between acetaminophen use in pregnancy and neurodevelopmental disorders
A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism and ADHD, offers reassurance that acetaminophen does not increase the risk of NDDs.
Emotional Archaeology: Excavating the Feelings Beneath ADHD
Discovering the emotions that shape reactions and relationships in ADHD.
After His Own Struggles Growing Up, Professor Dedicates ADHD Research to Helping Others Thrive
Josh Langberg received a $3.2 million National Institute of Mental Health grant to explore how virtual reality can help college students with ADHD minimize distractions and stay focused
USC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge
The research team created a new AI-powered tool that identifies and quantifies the part of the brain that connects the hemispheres and made it public to accelerate neuroscience research around the globe.
Massive database maps links between brain development and mental health
A new large-scale, open data resource from the Perelman School of Medicine and collaborators helps researchers link brain development with mental health disorders. Mental health disorders such as depression, anxiety, and ADHD affect millions worldwide and contribute significantly to the global burden of disease—impacting individuals' health and daily lives and placing a substantial strain on social systems and national and global economies.
Nonprofit See The Signs partners with WVU Rockefeller Neuroscience Institute to boost support for young people with ADHD
MORGANTOWN, W.Va. — When the founder of See The Signs, Inc., Elizabeth Esposito, decided to study attention-deficit/hyperactivity disorder (ADHD) for a seventh-grade project, she was surprised to discover some of the symptoms — such as having trouble focusing and staying on task — sounded familiar.
Cognitive issues in ADHD and learning difficulties appear to have different roots
A new study reports that the widespread cognitive difficulties in children with learning problems appear to be a core feature of their condition, independent of their attentional behaviors. In contrast, the more limited cognitive challenges found in children with Attention Deficit Hyperactivity Disorder (ADHD) who do not have learning difficulties may be consequences of their inattention and hyperactivity. The research was published in the Journal of Attention Disorders.
Familial link between ADHD and crime risk is partly genetic, study suggests
A new study has found that individuals with ADHD have a higher risk of being convicted of a crime, and reveals this connection also extends to their family members. The research suggests that shared genetics are a meaningful part of the explanation for this link. Published in Biological Psychology, the findings show that the risk of a criminal conviction increases with the degree of genetic relatedness to a relative with ADHD.
Changes to ADHD Guidelines and Tips for Treating ADHD
Discover the latest insights on ADHD diagnosis and treatment, including new DSM-5 criteria and effective therapeutic strategies for diverse patient needs.
The Skin–Brain Axis: Emerging Evidence Transforming Dermatologic Care
Research reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.
Health headlines can be confusing – these 3 questions can help you evaluate them
Every week of 2025 seems to bring a new health headline, whether it’s about climbing autism rates, changing vaccination recommendations or unexpected cancer risks. For people trying to make informed choices about their own health and that of their families, it can be tough to make sense of it all. The science can feel contradictory and confusing. Human data is messy, and studies often yield conflicting results.